Core Current Deferred Revenue from 2010 to 2024

CORZZ Stock   14.10  0.29  2.02%   
Core Scientific, Current Deferred Revenue yearly trend continues to be fairly stable with very little volatility. Current Deferred Revenue will likely drop to about 8.4 M in 2024. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2010-12-31
Previous Quarter
8.8 M
Current Value
8.4 M
Quarterly Volatility
32 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Core Scientific, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Scientific,'s main balance sheet or income statement drivers, such as Tax Provision of 645.4 K, Depreciation And Amortization of 116.5 M or Interest Expense of 63.8 M, as well as many indicators such as Price To Sales Ratio of 3.06, Dividend Yield of 0.0 or Days Sales Outstanding of 5.46. Core financial statements analysis is a perfect complement when working with Core Scientific, Valuation or Volatility modules.
  
Check out the analysis of Core Scientific, Correlation against competitors.

Latest Core Scientific,'s Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of Core Scientific, Tranche over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Core Scientific,'s Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Core Scientific,'s overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Pretty Stable
   Current Deferred Revenue   
       Timeline  

Core Current Deferred Revenue Regression Statistics

Arithmetic Mean41,818,243
Geometric Mean31,746,558
Coefficient Of Variation76.60
Mean Deviation17,381,510
Median44,843,000
Standard Deviation32,031,594
Sample Variance1026T
Range133.5M
R-Value(0.25)
Mean Square Error1037.7T
R-Squared0.06
Significance0.38
Slope(1,767,480)
Total Sum of Squares14364.3T

Core Current Deferred Revenue History

20248.4 M
20238.8 M
20219.8 M
2020141.9 M

About Core Scientific, Financial Statements

Core Scientific, investors use historical fundamental indicators, such as Core Scientific,'s Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Core Scientific,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue8.8 M8.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Core Stock Analysis

When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.